William Blair & Company
CVS icon

William Blair & Company’s CVS Health CVS Stock Holding History

William Blair & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43M Sell
61,734
-3,684
-6% -$284K 0.01% 527
2025
Q4 		$5.19M Buy
65,418
+2,009
+3% +$158K 0.01% 508
2025
Q3 		$4.78M Buy
63,409
+1,357
+2% +$93K 0.01% 525
2025
Q2 		$4.28M Buy
62,052
+525
+0.9% +$34.4K 0.01% 540
2025
Q1 		$4.17M Sell
61,527
-9,469
-13% -$567K 0.01% 533
2024
Q4 		$3.19M Sell
70,996
-36,875
-34% -$2.07M 0.01% 605
2024
Q3 		$6.78M Sell
107,871
-155,398
-59% -$9.07M 0.02% 423
2024
Q2 		$15.5M Sell
263,269
-149,538
-36% -$9.35M 0.05% 252
2024
Q1 		$32.9M Sell
412,807
-48,714
-11% -$3.72M 0.1% 156
2023
Q4 		$36.4M Sell
461,521
-12,177
-3% -$867K 0.12% 144
2023
Q3 		$33.1M Buy
473,698
+14,828
+3% +$1.05M 0.13% 145
2023
Q2 		$31.7M Sell
458,870
-50,430
-10% -$3.59M 0.12% 157
2023
Q1 		$37.8M Sell
509,300
-11,618
-2% -$974K 0.15% 133
2022
Q4 		$48.5M Sell
520,918
-14,613
-3% -$1.41M 0.21% 107
2022
Q3 		$51.1M Buy
535,531
+74
+0% +$7.33K 0.23% 101
2022
Q2 		$49.6M Buy
535,457
+6,321
+1% +$617K 0.22% 105
2022
Q1 		$53.6M Buy
529,136
+6,104
+1% +$641K 0.19% 117
2021
Q4 		$54M Buy
523,032
+113,532
+28% +$10.5M 0.17% 128
2021
Q3 		$34.8M Buy
409,500
+25,360
+7% +$2.12M 0.12% 165
2021
Q2 		$32.1M Buy
384,140
+36,783
+11% +$3.01M 0.11% 169
2021
Q1 		$26.1M Buy
347,357
+30,238
+10% +$2.2M 0.1% 185
2020
Q4 		$21.7M Buy
317,119
+6,005
+2% +$391K 0.08% 205
2020
Q3 		$18.2M Sell
311,114
-40,546
-12% -$2.52M 0.08% 200
2020
Q2 		$22.8M Buy
351,660
+14,923
+4% +$940K 0.11% 165
2020
Q1 		$20M Sell
336,737
-4,968
-1% -$332K 0.12% 157
2019
Q4 		$25.4M Buy
341,705
+13,530
+4% +$950K 0.13% 161
2019
Q3 		$20.7M Buy
328,175
+53,741
+20% +$3.18M 0.12% 171
2019
Q2 		$15M Buy
274,434
+4,878
+2% +$263K 0.09% 205
2019
Q1 		$14.5M Sell
269,556
-13,855
-5% -$855K 0.09% 207
2018
Q4 		$18.6M Buy
283,411
+35,444
+14% +$2.65M 0.14% 158
2018
Q3 		$19.5M Sell
247,967
-7,753
-3% -$554K 0.12% 174
2018
Q2 		$16.5M Buy
255,720
+22,200
+10% +$1.46M 0.11% 179
2018
Q1 		$14.5M Sell
233,520
-123,867
-35% -$8.89M 0.1% 185
2017
Q4 		$25.9M Buy
357,387
+98,663
+38% +$7.17M 0.18% 131
2017
Q3 		$21M Buy
258,724
+2,833
+1% +$224K 0.16% 145
2017
Q2 		$20.6M Buy
255,891
+39,335
+18% +$3.11M 0.15% 153
2017
Q1 		$17.3M Sell
216,556
-3,713
-2% -$296K 0.14% 168
2016
Q4 		$17.4M Sell
220,269
-48,197
-18% -$3.9M 0.16% 158
2016
Q3 		$23.9M Buy
268,466
+1,037
+0.4% +$97.9K 0.21% 117
2016
Q2 		$25.6M Sell
267,429
-63,510
-19% -$6.33M 0.24% 111
2016
Q1 		$34.3M Buy
330,939
+3,470
+1% +$337K 0.32% 88
2015
Q4 		$32M Buy
327,469
+81,912
+33% +$8.02M 0.3% 91
2015
Q3 		$23.7M Buy
245,557
+6,662
+3% +$700K 0.21% 127
2015
Q2 		$25.1M Buy
238,895
+3,168
+1% +$324K 0.04% 536
2015
Q1 		$24.3M Buy
235,727
+20,475
+10% +$2.07M 0.04% 523
2014
Q4 		$20.7M Sell
215,252
-8,205
-4% -$723K 0.03% 579
2014
Q3 		$17.8M Buy
223,457
+1,020
+0.5% +$80.4K 0.03% 619
2014
Q2 		$16.8M Buy
222,437
+4,576
+2% +$346K 0.03% 637
2014
Q1 		$16.3M Buy
217,861
+11,734
+6% +$829K 0.03% 643
2013
Q4 		$14.8M Sell
206,127
-47,293
-19% -$3.04M 0.02% 655
2013
Q3 		$14.4M Sell
253,420
-24,640
-9% -$1.47M 0.03% 617
2013
Q2 		$15.9M Buy
+278,060
New +$16.1M 0.03% 549

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company's CVS Position: Q1 2026 in Review

William Blair & Company reduced its CVS Health (CVS) stake by 5.6% in Q1 2026, selling an estimated $284K and leaving 61,734 shares worth $4.43M. The position accounts for 0.01% of the portfolio, ranked #527.

William Blair & Company first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $54M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • William Blair & Company held 61,734 shares of CVS Health worth $4.43M as of Q1 2026.
  • William Blair & Company sold 3,684 CVS Health shares in Q1 2026, an estimated $284K.
  • CVS Health made up 0.01% of William Blair & Company's portfolio in Q1 2026, its #527 holding.
  • William Blair & Company first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's CVS Health position peaked at $54M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.